IGF1 and Parkinson disease: Taken together, we conclude that, in our hands, insulin/IGF1 signaling, a modulator of aging, has indeed an effect—albeit opposite to what was expected, and cell-type specific—on the age-dependent loss of dopaminergic neurons in the C. elegans Parkinson’s disease model.